Purpose: To propose a simple method to correct vascular input function (VIF) due to inflow effects and to test whether the proposed method can provide more accurate VIFs for improved pharmacokinetic modeling. Methods: A spoiled gradient echo sequence-based inflow quantification and contrast agent concentration correction method was proposed. Simulations were conducted to illustrate improvement in the accuracy of VIF estimation and pharmacokinetic fitting. Animal studies with dynamic contrast-enhanced MR scans were conducted before, 1 week after, and 2 weeks after portal vein embolization (PVE) was performed in the left portal circulation of pigs. The proposed method was applied to correct the VIFs for model fitting. Pharmacokinetic parameters fitted using corrected and uncorrected VIFs were compared between different lobes and visits. Results: Simulation results demonstrated that the proposed method can improve accuracy of VIF estimation and pharmacokinetic fitting. In animal study results, pharmacokinetic fitting using corrected VIFs demonstrated changes in perfusion consistent with changes expected after PVE, whereas the perfusion estimates derived by uncorrected VIFs showed no significant changes. 
INTRODUCTION
Dynamic contrast-enhanced MRI (DCE-MRI) with pharmacokinetic modeling is an important method to assess the liver perfusion (1) and function (2) . It has been applied to the detection (3) and characterization (4) of malignancy, classification of fibrosis stage (5, 6) , and identification of cirrhosis (7) . The liver is a complex organ with two vascular sources: the hepatic artery and the portal vein. In the pharmacokinetic analysis of liver DCE-MRI, arterial input function (AIF) and portal venous input function (PIF) are both critical for accurate model fitting (1) . Any significant deviation from the real vascular input function (VIF) can lead to unreliable fitting results (8) .
Due to the limits in imaging spatial resolution, AIF and PIF usually are extracted from the abdominal aorta as a surrogate of the hepatic artery and the main portal vein, respectively, where the blood flow velocities are relatively high. In 3D T 1 -weighted spoiled gradient echo (SGRE) sequence, which is widely used in routine DCE protocols, axial excitation slabs are an efficient means to provide 3D volumetric coverage of the liver and the most commonly used strategy for liver imaging. However, as a result, unsaturated spins in fresh blood entering the excitation volume from above (aorta) or below (portal circulation) will lead to inflow enhancement due to the time-offlight effect.
Many researchers have attempted to acquire accurate VIF/AIF or provide alternatives when a reliable AIF is difficult to obtain. Phase-based AIF methods (9) measure the phase accumulation due to the susceptibility changes and transform the phase signal into the concentration of contrast agent. This method can avoid the magnitude saturation problems. However, it suffers from phase wrapping, flow-induced phase shift, or extended scan time due to a prolonged repetition time (TR). Moreover, the phase-based VIF/AIF extraction method is sensitive to signal-to-noise ratio (SNR) . A standard populationaveraged AIF (10) has also been proposed based on empirical equation fitting. This method is useful when a reliable AIF cannot be measured, and it can provide stable fitting results. The disadvantage of the populationaverage AIF approach is that it ignores the intersubject variance of cardiac output of different patients, which may introduce additional error. Saturation or inversion preparation pulses before acquisition (11) were commonly used to address the inflow problem as well. However, saturation and inversion pulses may reduce SNR performance and prolong scan time.
Roberts et al. quantitatively evaluated the influence of inflow effect and B 1 inhomogeneity on the AIF and the kinetics fitting using a flow phantom (12) . Recently, Ivancevic et al. proposed a method to fit a calibration equation that describes the relationship between contrast agent concentration and signal intensity using a flow phantom (13) . This method is limited in clinical application because it requires the use of a calibration experiment with flow phantom for any individual imaging protocol. Wang and Cao also proposed a method that assumes a peak of AIF, interpolates the AIF using a cubic spline, and optimizes the AIF using a two-input one-compartment model (1) with least squares method (8) . In addition, the extended radiofrequency (RF) excitation volume in the superior-inferior direction used with coronal or sagittal excitations may saturate the inflowing spins more effectively. However, with consideration of the balance between the spatial resolution and scan time, the axial acquisition is most commonly used because it can minimize the partial volume effect in vascular input function extraction (12) .
In this study, we propose a simple process to quantify the inflow enhancement effect from an SGRE-based DCE-MRI study and develop a method to correct the VIF for inflow effects, thereby providing more accurate pharmacokinetic modeling for liver DCE-MRI. Figure 1 shows examples of inflow-enhancement effects in the abdominal aorta (Fig. 1a) and portal vein (Fig. 1b) in the precontrast phase of the DCE-MR image of a pig. Such inflow enhancement will affect the contrast agent concentration estimation of VIFs, thus resulting in inaccurate pharmacokinetic parameter estimation. The protons in the hepatic arteries and portal veins must pass through the capillary bed in the liver before reaching the hepatic veins. Because the liver is fully included in the field of view (FOV), it is reasonable to assume that blood in the small branch of the hepatic vein has experienced a sufficient number of RF pulses and reached the steady-state M ss z . Supporting Figure S1 provides enhancements of the aorta, portal vein, and hepatic vein observed on the in vivo DCE scan, which also can serve as evidence of this assumption. Thus, the equilibrium magnetization M 0 z can be calculated using the SGRE steady-state equation (14, 15) :
THEORY
where TR is the repetition time and a is the flip angle.
On the other hand, due to the high blood velocity, the blood in the abdominal aorta and the main branches of portal vein may only experience a limited number of pulses and may not reach the SGRE steady state. In the phases before contrast agent injection, the number of pulses that the blood spins have experienced, N p , can be estimated (15) using the equation:
where M ðNpÞ z is the magnetization of spin. As it can be seen from Equation [2] , N p is derived directly from the equation without the knowledge of the flow pattern or flow speed. N p is a quantitative parameter to describe the inflow enhancement. Please see the Appendix (available online) for the complete derivation of Equation [2] .
Smaller N p occurs when a spin moves very fast or is near the border of an imaging volume to experience an insufficient number of pulses for the magnetization to approach the steady state, resulting in significant inflow enhancement, whereas larger N p occurs when a spin flows slowly or is far away from the margin of FOV, thus having milder inflow enhancement effect. Because the temporal resolution of the liver DCE-MRI is usually much lower than cardiac pulsation, it is reasonable to assume that inflow enhancement effects are independent of cardiac phase, and we note that portal flow is nonpulsatile and therefore independent of cardiac pulsatility. Thus, the T 1 of blood after contrast agent injection can be estimated phase by phase using Equation [2] if M 0 z and N p are known or can be measured.
The aorta and portal vein can be approximated as straight within the imaging volume; therefore, the distance that the blood inside these vessels has traveled can be considered as straight as well. Hence, the mean velocity of the flowing spin can be approximated as:
where D is the travel distance of a flowing spin, which can be measured from the images directly. Figure 2 is the flowchart of the proposed correction method using the PIF as an example.
METHODS

Simulation Study
To test whether the proposed method can estimate the inflow enhancement and effectively correct the contrast agent concentration of VIFs for more accurate pharmacokinetic analysis, a numerical phantom consisting of an aorta, portal vein, and static liver tissue was designed (Fig. 3) . The diameters of the aorta and portal vein were set to 17 mm (16) and 11 mm (17), respectively. Because both the aorta and portal vein are large vessels, with a diameter larger than 5 mm, plug flow pattern was simulated for both vessels (18) (19) (20) . Although the velocity of the aorta is pulsatile, the temporal resolution of each DCE-MRI time frame is generally much lower than the cardiac cycle; therefore, the velocity of the aorta was set as the mean velocity of diastole and systole, which was 0.5 m/s (21, 22) . The velocity of the portal vein is relatively stable along time (23, 24) ; however, a constant velocity was set to 0.3 m/s (17) . The concentration curve of AIF was simulated using the empirical equation (25)
As for the PIF, the second term of the empirical equation [6] , the concentration curve is derived with the T 1 curve. (e) Assuming the blood travels straightly along the vessel, the distance can be approximated from the image directly. Then, the spoiled gradient echo sequence-based blood velocity can be calculated using Equation [3] because the effective flow time is about repetition time* N p .
was used because it is not the first pass of contrast agent. The equation parameters for VIFs were fitted with a set of real patient DCE data (26) . The parameters for AIF were: ¼ r 1 CðtÞ; [6] where T pre 1 is the T 1 value before contrast agent injection, which was set to 1,932 ms for blood and 812 ms for liver tissue (27) , respectively. A typical R1 relaxivity, r 1 , of a gadolinium contrast agent was set to 4.5/mM/s (28) at 3.0T in this simulation.
The imaging parameters of SGRE for simulation were:
. The blood will reach 99% of the steady state when N p is larger than about 200, based on Equation [2] assuming these parameters. The true N p of vessel pixel was calculated by the flow velocity and distance of inflow using Equation [3] . The corresponding signal intensity can be calculated using Equation [2] phase by phase. Complex random noise of 50 dB was added to the raw Cartesian k-space before image reconstruction. The definition of SNR used for these simulations was SNR ¼ 10log 10 Psig Pnoise , where P sig is the mean power of k-space signal and P noise is the mean power of noise.
The proposed method was employed to quantify the N p of the flowing spins from the reconstructed images. To evaluate the accuracy of inflow quantification of the proposed method, mean and standard deviation (SD) of the estimated N p errors of all the pixels with the same value of true N p were calculated. To evaluate the improvement of the proposed method on T 1 and contrast agent concentration estimation, the mean and SD of estimation errors of both methods were calculated and compared with paired Student t test.
To further explore the impact of inflow enhancement of VIFs on the pharmacokinetic model analysis and test the performance of the proposed method, the pharmacokinetic parameters were fitted using the tissue curves and VIFs with different N p values. With the plug flow setting in this simulation, the N p can be converted to the location selected for VIF extraction (the distance to the edge of FOV in the inflow side) using Equation [3] , which is more intuitive in practical DCE analysis. In this simulation, only N p values less than 200 were tested because the blood can be considered as reaching the steady state when N p is larger than about 200. The mean ratios of errors of pharmacokinetic parameters, including arterial perfusion, portal venous perfusion, and arterial fraction-fitted by VIFs with and without correctionwere calculated, respectively.
In Vivo Experiments
In vivo animal experiments were performed after approval of the Institutional Animal Care and Use Committee. Thirteen domestic pigs (all female, mean weight 54 kg) were studied. Portal vein embolization (PVE) of the left lateral and left middle branches of the portal vein was performed using nonspherical polyvinyl alcohol particles via a transcutaneous, transhepatic approach. For each pig, embolization was performed until complete stasis of flow under fluoroscopy flow in the catheterized branches was achieved.
All pigs were then imaged using a 3.0T clinical MRI system (Discovery MR750, GE Healthcare, Waukesha, Wisconsin, USA) using a 32-channel phased-array torso coil (NeoCoil, Pewaukee, Wisconsin, USA) under anesthesia. Imaging was performed before PVE (visit 1), and 1 week (visit 2) and 2 weeks (visit 3) after PVE. Dynamic contrast-enhanced imaging was conducted using a respiratory navigator triggered dual-echo differential subsampling with Cartesian ordering sequence (29) 2 via sinc interpolation. Dual-echo acquisition was used to facilitate fat suppression via standard Dixon water-fat separation as part of the differential subsampling with Cartesian ordering application. Respiratory gating was performed using a 2D pencil beam navigator placed on the right liver dome, with the acceptance window set to 30%. View-sharing was performed with a temporal resolution of 7.0 s. After the precontrast mask acquisition, 0.03 mmol/kg of gadofosveset trisodium (Ablavar, Lantheus Medical, North Billerica, Massachusetts, USA) was injected through the marginal ear vein at a rate of 2 mL/s, followed by 15 mL 0.9% saline solution flush injected at the same rate. A total of 20 dynamic phases were acquired during the dynamic scan over approximately 2.3 minutes.
In addition, 4D-flow MRI of the portal vein was also performed on six pigs at each of the three visits using phase-contrast vastly undersampled isotropic projection reconstruction (30) 3 , and spatial resolution ¼ 1.4 Â 1.4 Â 1.4 mm 3 . Data were reconstructed to 14 time frames per cardiac cycle.
Image Analysis
Dynamic contrast-enhanced images were reformatted into the coronal plane for better visualization of the aorta and portal vein. A Gaussian filter with a kernel size of 3 Â 3 Â 3 and SD of 0.65 was applied to all the phases of DCE images for smoothing (31) . Next, a region of interest (ROI) containing about 10 pixels was drawn in the right branch of the hepatic vein on the precontrast phase by free hand for M 0 z calculation. The mean signal intensity of ROI of the precontrast dynamic phase, M ss z , was used to calculate M 0 z , assuming a precontrast blood T 1 value of 1,932 ms (27) by Equation [1] . Regions of interest for AIF and PIF extraction were then selected in the abdominal aorta and portal vein at the level of porta hepatis, respectively, which are distal of the vessels and should have the largest N p . The N p was calculated from the precontrast image for the ROIs of AIF and PIF with Equation [2] . The ROIs for AIF and PIF were copied and pasted to all phases, and the corresponding T 1 curve after contrast agent injection was calculated using Equation [2] , with the N p value estimated from the previous steps. The approximate inflow distance of blood, D, in the abdominal aorta or portal vein was measured from the DCE images. The SGRE-based flow velocity v SGRE can be calculated using Equation [3] .
For each visit of all pigs, ROIs of the left (embolized side) and right (control side) lobes were selected on the DCE images to evaluate local perfusion parameters. Regions of interest of tissue were manually drawn to avoid large vessels and bile ducts. The T 1 values of liver tissue of dynamic phases after contrast agent injection were calculated using Equation [1] . Assuming an intrinsic liver tissue precontrast T 1 value of 812 ms (27) , the contrast agent concentration curves of liver tissue can be converted using Equation [6] . In this study, r1 of Ablavar was set as 5.3 mM À1 s À1 on 3T (28). The same dual-input one-compartment model (1) was employed to fit the in vivo tissue curves, along with the AIF and PIF curves with and without correction. The nonlinear least square algorithm was adopted for the model fitting. The fitted perfusion parameters using both the corrected and uncorrected VIFs were compared with paired Student t test to determine whether the two methods provided significantly different results. For fitted results of both methods, the perfusion parameters were compared between the left and right lobes, and between each of the two different visits using paired Student t test to inspect whether the perfusion parameters changed due to PVE surgery as well.
Flow measurements from 4D-flow MRI were performed in EnSight (CEI, Apex, North Carolina, USA) using manual placement of cut-planes in the vessel of interest. The mean velocities, v 4DÀflow , of six pigs, 18 visits in total were analyzed for comparison. The intraclass correlation coefficient was employed to compare the consistency of v SGRE and v 4DÀflow .
RESULTS
Simulation Study
The mean and SD of the error of estimated N p are shown in Figure 4a . When N p was relatively small, the error of estimated N p was almost zero; when N p was larger, the error of estimated N p by the proposed method became evident. Roughly, the mean and SD increased with larger N p . The mean and SD of the estimated T 1 and contrast agent concentration errors with different N p values are shown in Figures 4b and 4c , respectively. With increasing N p , both the mean and SD of estimated T 1 error decreased; however, the absolute mean T 1 estimation error of uncorrected method was larger than that of the corrected method (P < 0.001). The SD of estimated T 1 error of the uncorrected method was also larger than the corrected method (P < 0.001). Regarding the concentration estimation error of the two methods, the absolute mean and SD of the estimated concentration error were larger than the corrected concentration (P < 0.001). In general, the uncorrected method underestimated the contrast agent concentration by a considerable amount, whereas the proposed method provided more accurate (mean error 0.13 mM versus À1.43 mM of the uncorrected method), although slightly overestimated, contrast agent concentration. Figure 5 plots the ratio of error of the fitted pharmacokinetic parameters using the corrected and uncorrected VIFs of different N p values. Regarding arterial and portal venous perfusion, the absolute error of both methods decreased when N p increased, whereas the estimations with corrected VIFs had a lower absolute error than the uncorrected VIFs in all the tested circumstances. Regarding the arterial fraction, the absolute error of the proposed method was also relatively lower than the uncorrected results, in general. It is worth noting that the estimated AF was less affected when the inflow enhancement effects of the aorta and portal vein were close. When the N p of the aorta was much smaller than the portal vein, the AF was overestimated in the uncorrected VIFs. Otherwise, the AF was underestimated.
In Vivo Experiments
Examples of estimated N p and v SGRE along the aorta and portal vein are shown in Figure 6 . In the in vivo results, the mean N p of the selected ROIs was 80 for AIF and 100 for PIF, respectively, which was the largest that we can obtain in the vessels.
A typical example of AIF and PIF with and without correction of the in vivo experiments is shown in Figure  7 . Although the flow velocity derived with the correction method vary considerably in the portal vein, the contrast concentrations along the portal vein vary to a far lesser extent (as shown in Supporting Figure S2 , available online). The corrected AIF and PIF by the proposed inflow quantification and correction method were much higher for the uncorrected curves. Notably, the uncorrected PIF had a higher peak than the uncorrected AIF, which might be caused by the higher N p in the aorta. This nonphysiologically possible observation disappeared after correction.
The paired Student t tests comparing in vivo fitted perfusion parameters: arterial perfusion (Fig. 8a) , portal venous perfusion (Fig. 8b) , and arterial fraction (Fig. 8c ) of all the lobes and visits, between the results with correction and without correction, are shown in Figure 8 . The arterial perfusion and portal venous perfusion fitted by the uncorrected VIFs were nonphysiologically high (larger than 1,000 mL/100 mL/min). The arterial and portal venous perfusion parameter estimates were much more reasonable using the proposed corrected VIF method (around 65 mL/100 mL/min for arterial perfusion, 358 mL/100mL/min for portal venous perfusion). The arterial fraction estimated using corrected VIFs was also higher than the corrected one, similar to the simulation results. Figure 9 shows the results of comparing the perfusion parameters of the left and right lobes of pigs among different visits. Regarding the results of the proposed method, the portal venous perfusion of the left lobe decreased (P < 0.001) after PVE, whereas the arterial fraction increased (P < 0.001) from baseline (visit 1) compared to 1 week after PVE (visit 2). The data from visit 2 (1 week after PVE) showed that the corrected portal venous perfusion of the left lobe was lower than the right lobe (P ¼ 0.016), whereas the corrected arterial fraction was higher than the right lobe (P < 0.001). The arterial fraction significantly decreased (P ¼ 0.003) from 1 week after PVE (visit 2) to 2 weeks after PVE (visit 3). However, there was no significant difference found between the left and right lobes, or each of the two different visits, from the result of the uncorrected VIFs.
Regarding the portal vein velocity comparison between v SGRE and v 4DÀflow , the intraclass correlation coefficient of two measurements was 0.855. Figure 10 is the scatter plot of velocities of the portal vein measured from the precontrast of DCE images and the 4D-flow MRI images. Good consistency of two measurements could be observed from the results.
DISCUSSION
In this study, a new method that corrects the vascular input function of inflow enhancement method was proposed to improve the accuracy of perfusion quantification using DCE-MRI of the liver. Based on simulations and the study of pigs that have undergone portal vein embolization, the proposed method appears to alleviate the effects of inflow enhancement. This method is compatible with routine DCE acquisition protocols, without any need for complex calibration steps or other postprocessing. In addition, the proposed method has the potential to apply to many scenarios in which the imaging volume is limited and contains large vessels.
The simulations of conventional T 1 and concentration estimation showed that a lack of correction for partially saturated spins can lead to underestimation of the apparent gadolinium concentration, resulting in the subsequent overestimation of arterial and portal venous perfusion. Furthermore, differences of inflow enhancement in the aorta and portal vein would lead to error in the estimation of AF. In both simulations and the animal experiments, the proposed method effectively corrected VIFs with different inflow enhancement effects and provided more accurate estimates of AF. The T 1 and concentration estimations of the proposed method performed very well, except for N p ¼ 1. This is because when N p ¼ 1, the signal intensity is less T 1 -dependent and the contrast is proton density-weighted such that it is not possible to reliably estimate contrast agent concentration. However, the case when N p ¼ 1 is likely of no practical consequence because this case only affects pixels 1.2 to 2 mm away from the edge of the imaging volume.
The in vivo experiments further validated the simulation results. The arterial and portal venous perfusions calculated using the uncorrected VIFs were unrealistically high, which likely resulted from marked underestimation of the contrast agent concentration. The overestimation of the arterial fraction may result from different levels of inflow enhancements due to different flow velocities in the aorta and portal vein. The proposed method corrected underestimation of the VIF curves and lead to perfusion parameter estimates within a reasonable physiological range (5, 32) . Furthermore, the consistency of portal vein velocities measured from the precontrast DCE images using the proposed method and the 4D-flow MRI results served as a side evidence for the quantitation accuracy of the proposed method.
More importantly, unlike the conventional perfusion estimation method, the inflow corrected method could detect physiologically feasible changes after portal vein embolization. Compared to baseline, the portal venous perfusion decreased 1 week after embolization in the left lobe due to reduced blood flow in the portal vein branches. The arterial perfusion of the left lobe increased in visit 2, although not significantly, reflecting the known compensatory hepatic arterial buffer response of the liver (33) . As one of the few organs with two independent vascular supplies, the liver can upregulate perfusion of one vascular supply if the other one is compromised (34) . As a result, the arterial perfusion increased after PVE in the embolized liver segments. Two weeks after PVE, portal venous perfusion and arterial perfusion reached almost baseline levels. This may be due to recanalization of the embolized portal vein branches. Because only particles have been used for embolization instead of a coil, the rate of recanalization is relatively high (35) . On the other hand, with the uncorrected VIFs the portal venous perfusion decreased but not significantly, whereas the arterial perfusion and arterial fraction of the embolized lobe decreased from visit 1 to visit 2, which was not consistent with the PVE procedure. This most likely results from error related to the different inflow enhancement effects of the aorta and the portal vein. In addition, the portal venous flow might change after the PVE, which could further disturb the estimation of pharmacokinetic analysis.
There are also some limitations of this study. First, we recognize that the distribution of imaging flip angle may not be perfectly homogeneous within FOV, and variable flip angles near the edge of the imaging volume will introduce additional error (12) . Although beyond the scope of this work, the impact of a nonuniform flip angle profile in principle could be incorporated into refined correction methods. Because the purpose of this work was to demonstrate the impact of inflow enhancement and the feasibility of inflow enhancement correction, the inhomogeneity of B 1 field was not taken into consideration. Second, no ground truth of perfusion can serve as a reference for the in vivo perfusion parameter fitting. Thus, numerical simulations were used in this study to validate the proposed method, and the in vivo experiment with animals after PVE further indicated its feasibility. A flow phantom with true velocity information should further benefit the validation in future studies.
An additional limitation of this study is that, due to the lack of T 1 measurement, the precontrast T 1 values of arterial and venous blood were assumed to be the same. This could have contributed to a systematic error in the estimation of concentration. The 6 20% of T 1 error will finally cause 60%$30% of concentration error (reference T1 ¼ 1,932 ms; N p ¼ 80; and concentration ¼ 1 mM). Please note that the proposed method can only correct the underestimation of vascular input function due to the inflow. When incorporating T Ã 2 correction (36) or double-injection methods (37, 38) , the saturation of vascular input function due to both the high concentration of contrast agent and inflow may be improved.
In conclusion, the proposed vascular input function correction method of inflow enhancement is a relatively straightforward and efficient way to provide more reliable VIFs for improved pharmacokinetic modeling and perfusion quantification in the liver using DCE-MRI.
